Pyrazole Derivatives Modulating 5-HT2A Receptor for Sleep and Platelet Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for sleep disorders and conditions associated with 5-HT2A serotonin receptor activity, such as insomnia and platelet aggregation, often have limitations in efficacy and side effects, and there is a need for a pharmacological agent that can effectively modulate 5-HT2A serotonin receptor activity to improve sleep quality and reduce platelet aggregation.
Innovation Solution
Development of pyrazole derivatives and their pharmaceutical compositions, specifically hydrochloride salts, which act as modulators of 5-HT2A serotonin receptor activity, prepared through specific reaction processes involving compounds of Formula (I), (II), (III), (IV), (V), and (VI), to treat various disorders including insomnia, coronary artery disease, and platelet aggregation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments for sleep disorders and 5-HT2A serotonin receptor conditions are used, then treatment availability is maintained, but efficacy is limited and side effects occur
Solution Approach 1:
The patent employs parameter changes by developing novel pyrazole derivative compounds with specific molecular structures (Formula I) that modify the pharmacological parameters of 5-HT2A serotonin receptor modulation. The compounds feature variable substituents (R1-R6) that can be adjusted to optimize efficacy while minimizing side effects, representing a systematic parameter change approach to drug development
Solution Approach 2:
The invention creates composite chemical structures by combining pyrazole core compounds with various substituent groups (aromatic rings, heterocyclic groups, alkyl chains) to form complex molecular compounds. These composite structures enable fine-tuned interaction with the 5-HT2A receptor, achieving better therapeutic profiles compared to simpler existing treatments
2Reliability
If existing pharmacological agents are used, then treatment coverage is provided, but sleep quality improvement is insufficient and platelet aggregation reduction is limited
Solution Approach 1:
The patent applies segmentation by dividing the therapeutic effect into multiple targets: (1) modulation of 5-HT2A serotonin receptor activity to improve sleep quality, and (2) inhibition of platelet aggregation. The pyrazole derivative compounds are designed to simultaneously address both objectives, segmenting the overall therapeutic goal into manageable pharmacological actions
Solution Approach 2:
The invention achieves universality by designing pyrazole derivative compounds that perform multiple functions: they act as 5-HT2A serotonin receptor modulators to treat sleep disorders, while simultaneously serving as platelet aggregation inhibitors. This multi-functionality allows a single compound to address both sleep quality improvement and platelet aggregation reduction
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The pyrazole derivatives effectively treat sleep disorders by improving sleep quality and reducing platelet aggregation, offering a more effective and safer alternative to existing treatments by modulating 5-HT2A serotonin receptor activity.
Implementation Method 1
reacting a compound of Formula (II) with a compound of Formula (III) to form a compound of Formula (I)
Data Source
AI summary
The present invention relates to processes for preparing pyrazole derivatives of Formula (I) and salts and pharmaceutical compositions of the salts thereof, useful as modulators of 5-HT2A serotonin receptor activity.The present invention also relates to intermediates used in the processes, and their preparation. The present invention also relates to salts of compounds of Formula (I) and pharmaceutical compositions thereof.